Dec 21, 2019 · Azathioprine (AZA) and mycophenolate mofetil (MMF) are both first-line steroid-sparing agents used for the treatment of pemphigus in combination with a
May 1, 1996 · Treatment complications include radiation pneumonitis that may require therapy with corticosteroids which possess significant side effects
May 1, 1996 · We report the use of azathioprine as a steroid-sparing agent in a patient with severe radiation pneumonitis and steroid-induced myopathy
1993; 129: 49-53
Conclusion: Azathioprine is a good adjuvant immunosuppressive drug in the control
Azathioprine is often considered as a These immunomodulating agents serve as the foundation to modern corticosteroid-sparing immunosuppressive therapy
22,30 In comparison with other steroid-sparing options, azathioprine has more favorable tolerability, although a major challenge in its clinical use is the estimated
The advent of biological therapies has increased interest in targeted therapies
Data from a single small RCT suggest that low-dose corticosteroids may be effective for ocular MG and may avoid side effects associated with high-dose corticosteroids (median 9, range 4–9)
Crossref
Side effects attributable to steroids were equally common in both groups; infections were not increased in the combination therapy group
November 26, 2018
The First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial was a National Eye Institute–supported multicenter, randomized, parallel, observer-masked clinical trial at 9 referral eye care centers in India, the United States, Australia, Saudi Arabia, and Mexico
Azathioprine and mycophenolate mofetil, among others, have been reported in case series for successful
To our knowledge, this is the first report in the literature in which azathioprine was used to treat radiation pneumonitis
97) 2981
Rituximab is extremely effective in recalcitrant pemphigus, when other treatments fail to control the disease
Azathioprine and 6-mercaptopurine are thiopurines, and azathioprine is an imidazolyl derivative of 6-mercaptopurine